We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$16.8B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+23.77%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$58.1B
AUM Growth
+$9.39B
(+19%)
Cap. Flow
-$245M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
13.23%
Holding
2,444
New
480
Increased
936
Reduced
725
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$647M |
| 2 |
Cognizant
CTSH
|
+$631M |
| 3 |
Caterpillar
CAT
|
+$236M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$133M |
| 5 |
American International
AIG
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$529M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$193M |
| 4 |
Lowe's Companies
LOW
|
+$162M |
| 5 |
Teladoc Health
TDOC
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.96% |
| 2 | Technology | 16.82% |
| 3 | Financials | 13.96% |
| 4 | Industrials | 9.56% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Medifast
MED
$108M
| $62K | ﹤0.01% |
447
-553
| -55% | -$50.8K |
|
1827
RB Global
RBA
$20.8B
| $62K | ﹤0.01% |
+1,538
| New | +$62.9K |
|
|
DRNA
1828
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $62K | ﹤0.01% |
+2,443
| New | +$52.6K |
|
1829
Kodiak Sciences
KOD
$2.59B
| $61K | ﹤0.01% |
+1,124
| New | +$63.4K |
|
1830
Akebia Therapeutics
AKBA
$327M
| $60K | ﹤0.01% |
+4,403
| New | +$45.6K |
|
|
CIM
1831
Chimera Investment
CIM
$1.05B
| $60K | ﹤0.01% |
+2,075
| New | +$53.3K |
|
|
CSW
1832
CSW Industrials
CSW
$4.71B
| $60K | ﹤0.01% |
+874
| New | +$59K |
|
1833
InterDigital
IDCC
$6.68B
| $60K | ﹤0.01% |
+1,062
| New | +$56.5K |
|
1834
Texas Capital Bancshares
TCBI
$4.31B
| $60K | ﹤0.01% |
1,930
+530
| +38% | +$14.8K |
|
|
TRTN
1835
DELISTED
Triton International Limited
TRTN
| $60K | ﹤0.01% |
+1,969
| New | +$58.5K |
|
1836
Cardlytics
CDLX
$21M
| $59K | ﹤0.01% |
+85
| New | +$49.1K |
|
1837
Green Dot
GDOT
$753M
| $59K | ﹤0.01% |
+1,196
| New | +$40.5K |
|
1838
Glaukos
GKOS
$9.02B
| $59K | ﹤0.01% |
1,523
-37,214
| -96% | -$1.39M |
|
1839
Phibro Animal Health
PAHC
$1.38B
| $59K | ﹤0.01% |
2,235
-1,975
| -47% | -$49K |
|
1840
Cerence
CRNC
$382M
| $58K | ﹤0.01% |
+1,428
| New | +$41K |
|
1841
Franklin Electric
FELE
$4.67B
| $58K | ﹤0.01% |
+1,095
| New | +$54.4K |
|
1842
Mercury Insurance
MCY
$5.94B
| $58K | ﹤0.01% |
+1,427
| New | +$57.3K |
|
1843
RE/MAX Holdings
RMAX
$200M
| $58K | ﹤0.01% |
1,860
-2,040
| -52% | -$54.1K |
|
1844
Safety Insurance
SAFT
$1.52B
| $58K | ﹤0.01% |
+759
| New | +$59.4K |
|
|
BBBY
1845
DELISTED
Bed Bath & Beyond Inc
BBBY
| $58K | ﹤0.01% |
5,435
-39,065
| -88% | -$269K |
|
1846
GrafTech
EAF
$194M
| $57K | ﹤0.01% |
720
-18,130
| -96% | -$1.36M |
|
1847
iShares Russell 2000 ETF
IWM
$80.9B
| $57K | ﹤0.01% |
400
-318
| -44% | -$41.7K |
|
1848
Rogers Corp
ROG
$2.33B
| $57K | ﹤0.01% |
+461
| New | +$49.3K |
|
|
SFBS
1849
ServisFirst Bancshares
SFBS
$4.79B
| $57K | ﹤0.01% |
1,584
+480
| +43% | +$15.8K |
|
|
PRNB
1850
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $57K | ﹤0.01% |
+958
| New | +$59.2K |
|
Similar funds
AIMCA
CI
BCIM
VMPIC
EIP
PP
ASRS
CM
Macquarie Group's Q2 2020 Portfolio in Review
As of Q2 2020, Macquarie Group held 2,444 positions worth $58.1B, up 19% from $48.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Macquarie Group's Q2 2020 filing shows 480 new, 936 increased, 725 reduced and 86 closed positions. Its largest new stake was LGI Homes: 1,071,112 shares worth $94.3M. The largest sale was Raytheon Company, an estimated $529M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
- Macquarie Group's largest Q2 2020 buy was LGI Homes: 1,071,112 shares worth $94.3M.
- Macquarie Group added most to RTX Corp in Q2 2020, an estimated $647M increase.
- Macquarie Group's biggest Q2 2020 reduction was Occidental Petroleum, cutting an estimated $321M.
- Macquarie Group fully exited Raytheon Company in Q2 2020, selling an estimated $529M.
- Macquarie Group's ten largest holdings make up 13% of its $58.1B portfolio in Q2 2020.
- Macquarie Group opened 480 new positions and closed 86 in Q2 2020.
- Macquarie Group's portfolio value rose 19% quarter-over-quarter to $58.1B.
Based on Macquarie Group's 13F filing for Q2 2020, filed 11 Aug 2020.